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Critical pulmonary stenosisAbstract Background: Balloon pulmonary valvuloplasty (BPV) represents the standard of man-
agement for all patients with severe pulmonary stenosis (PS) irrespective of their age. Nevertheless
neonates and infants with critical PS represent a high-risk group that needs to be studied.
Methods: The study population included 72 infants with severe congenital valvular PS and four
infants with imperforate pulmonary valve (PV) who were subjected to detailed history taking, full
clinical examination, resting 12-lead ECG, Chest roentgenogram and transthoracic echocardiogra-
phy. BPV was attempted in all infants with a peak-to-peak gradient across the PV of 50 mmHg or
greater at catheterization-laboratory. Full echocardiographic evaluation was done 24 hours after
the procedure as well as 3 and 6 months later.
Results: Seventy-six infants with severe PS or imperforate PV with a mean age of 5.63 ±
2.99 months were subjected to BPV with or without wire perforation. Immediately after the proce-
dure patients had a signiﬁcant reduction of the right ventricular systolic pressure (RVSP)
(104.69 ± 24.98 mm Hg Vs 43.6 ± 13 mm Hg, p< 0.001) and RV-PA systolic pressure gradient
(PG) (82.5 ± 23.76 mm Hg Vs 17.35 ± 8.96 mm Hg, p< 0.001). The immediate success rate
deﬁned as the drop in the RVSP to less than or equal to 50% of the baseline measurement was
achieved in 85% of the cases. There was a progressive drop in the PG across the PV by Doppler
echocardiogram throughout a follow-up period of six months from a mean of 93.3 ± 28.2 mm Hg
to a mean of 17.4 ± 10.42 mm Hg (p< 0.001). There was a signiﬁcant increase of the mean PV
annulus diameter after balloon dilatation (p< 0.001). There was also a highly signiﬁcant inverse
correlation between the growth of the pulmonary annulus and the annular size at the baseline
before dilatation (r= 0.74, p value <0.001). The incidence of PR signiﬁcantly increased immedi-
ately after BPV to 64% followed by a progressive decline over a 6 months period of follow-up to
20%. There was a signiﬁcant decrease in the incidence of tricuspid regurgitation (TR) over the same
period of follow-up (from 55.6% at baseline to less than 20% at follow-up).
Conclusion: BPV is safe and effective to relieve critical PS in infants during the ﬁrst year of life. The
balloon promotes advantageous changes in both, pulmonary annulus and PG across the RVOT. In
addition, the Doppler gradient observations during the follow-up support the expectation that BPV
is a ‘‘curative’’ therapy.
ª 2010 King Saud University. All rights reserved.1. Introduction
The incidence of valvular pulmonary stenosis (PS) has been
reported at 0.6 to 0.8 per 1000 live births, and when associ-
ated with other congenital cardiac lesions, it may occur in
as many as 50% of all patients with congenital heart disease
(Botto et al., 2001; Hoffman and Kaplan, 2002). Dysplastic
valves consisting of thickened, irregular, immobile tissue, of-
ten with hypoplasia of the valve annulus and a small short
main pulmonary artery are much less common (Becu et al.,
1976).
The traditional method of treatment for this obstructive
lesion was surgical valvotomy up to 1982, when Kan et al.
(1982) introduced the technique of percutaneous balloon pul-
monary valvuloplasty (BPV). The short- and mid-term results
of BPV have been so good that nowadays it has become the
preferred method of therapy for moderate and severe PS both
in children as well as adults. It is also safe and effective for
relief of PS in neonates (Ray et al., 1993; Shrivastava et al.,
1993).
Neonates and infants with critical PS with right ventricular
(RV) pressure equal to or greater than systemic pressure can be
categorized into two distinct groups based on their clinical pre-
sentation: (1) critically ill infants with cyanosis whose pulmon-
ary blood ﬂow may depend on ductal patency and require
urgent intervention and (2) asymptomatic infants. The ana-
tomic and hemodynamic factors that determine the clinical
presentation of infants with critical PS are not well understood
(Nugent et al., 1977).The success rates of BPV in infants with critical PS have
been reported to be 55–94%; however, restenosis has been re-
ported in 17–36% of these patients. The pulmonary valve (PV)
annulus and right heart structures have been characterized as
hypoplastic in some patients with critical PS, and growth of
these structures relative to somatic growth after balloon pul-
monary valvuloplasty has been a subject of controversy (Caspi
et al., 1990; Gournay et al., 1995; Talsma et al., 1993; Zeevi
et al., 1988).
2. Methods
This study was approved by our institutional review board and
informed consent was obtained from the parents of all the chil-
dren enrolled in the study.
2.1. Study population
The study included all infants under the age of 1 year who were
referred for elective BPV in the Pediatric Cardiology Unit,
Cardiology Department, Ain Shams University Hospital be-
cause of severe valvular PS or imperforate PV over 2 years
time ending in December 2009.
2.2. Inclusion criteria
Patients who fulﬁlled the following criteria were selected for
balloon dilatation of the PV: Age from birth to one year,
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dient (PG) across the PV of >50 mm Hg regardless of symp-
toms, valve morphology or associated congenital anomalies
such as small atrial septal defect (ASD), patent foramen ovale
(PFO), small ventricular septal defect (VSD), or patent ductus
arteriosus (PDA).
2.3. Exclusion criteria
 Patients with associated large VSD or ASD or any other
associated anomaly in which the dilatation of the PV would
lead to increased risk of development of pulmonary hyper-
tension in the future
 Patient with multiple levels of right ventricular outﬂow tract
(RVOT) obstruction who would not beneﬁt from BPV.2.4. Methods
2.4.1. Chest roentgenography and electrocardiography
Chest roentgenographs and electrocardiograms (ECG) were
analyzed for chamber enlargement and lung vasculature.
2.4.2. Complete laboratory evaluation
Complete laboratory evaluation was carried out before
catheterization.
2.4.3. Transthoracic Echocardiography (TTE)
TTE examinations were performed using a GE ViVid 5 echo-
cardiography machine with phased array transducers. Stan-
dard echocardiographic views (parasternal long and short
axis, apical 4, 2 and 5-chamber, subcostal and suprasternal
views) in addition to color Doppler and continuous-wave
Doppler were taken to study RV dimensions (Frommelt and
Frommelt, 1999), PV morphology and ﬂow, PV annulus and
its Z-value and tricuspid valve annulus and its Z-value (Z-va-
lue was used to standardize pulmonary and tricuspid valves
dimensions with body size). Z-scores <2 were taken to repre-
sent a small valve annulus while Z scores <3 marked a hypo-
plastic valve annulus (Gildein et al., 1996). Associated lesions
such as PFO, ASD, PDA, VSD, post-stenotic dilatation and
infundibular stenosis were noted. The maximum peak instan-
taneous systolic PG across the PV was quantiﬁed by the mod-Figure 1 Lateral angiograms showing inﬂated balloons across the p
disappearance of the waist in an infant with severe PS, (B) sausage-like
valve who underwent balloon dilatation after successful perforation oiﬁed Bernoulli equation (Hatle, 1982). The presence and
intensity of pulmonary regurgitation (PR) were assessed by
color ﬂow mapping. 2D Doppler echocardiographic examina-
tions were performed immediately before and one day after
BPV as well as 3 and 6 months later.2.4.4. Balloon pulmonary valvuloplasty
Premedication with a sedative and analgesic was given to all
cases, followed by local anesthesia. Continuous ECG moni-
toring and blood pressure measurement were carried out as
well as arterial oxygen saturation by means of a pulse
oximeter.
The femoral vein was accessed using Seldinger’s technique
and a 5–7 F sheath was introduced into the vein. Alternative
venous access sites were needed in selected cases. An angio-
graphic catheter was placed in the RVOT and straight lateral
angiograms were performed (1 cc/kg over one second) to mea-
sure the PV annulus and assess the RV and valve anatomy.
The angiographic catheter was replaced with an end-hole cath-
eter which was manipulated into the RV with the tip directed
toward the RVOT. The PV was crossed and the catheter posi-
tioned in the lower lobe branch of either the left or the right
pulmonary arteries. An exchange guide wire was placed in
the peripheral pulmonary artery and the catheter was replaced
with a dilatation balloon. The balloon was centered across the
valve annulus in the lateral view and rapidly inﬂated by hand
with diluted contrast material until the disappearance of the
waist (Fig. 1). The deﬂated balloon was then removed while
keeping the guide wire in the pulmonary artery. The guide wire
permitted repositioning of an end-hole catheter into the distal
pulmonary artery for pressure measurements (Moore and
Lock, 2000).
The following pressure and hemodynamic measurements
were recorded before and immediately after BPV: Right ven-
tricular systolic pressure (RVSP), right ventricular diastolic
pressure (RVDP), pulmonary artery systolic pressure (PASP),
Pulmonary artery diastolic pressure (PADP), RV to PA sys-
tolic PG.
The following data were also reported: Number of balloons
used, type and size of each balloon used, number of inﬂations
for each balloon, the maximum balloon annulus ratio used, theulmonary valve. (A) Successful inﬂation of the balloon with near
balloon with very tight waist in a case of imperforate pulmonary
f the pulmonary valve.
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infundibulum.
All procedural or post-procedural complications such as
respiratory or cardiac arrest, pericardial effusion or any vascu-
lar complication at the access site were recorded as well.
2.5. Statistical analysis
Continuous variables were expressed as mean ± standard
deviation. Qualitative variables were expressed as percentages.
A paired Student t test was used for the comparison of differ-
ent variables before versus immediately after BPV as well as
during the follow-up period. A P-value <0.05 was considered
statistically signiﬁcant. Linear correlation was applied to deter-
mine the relation between the baseline tricuspid and pulmon-
ary valves annuli and their measurements after dilatation.
3. Results
The current study included 76 infants below 1 year of age rep-
resenting 27.1% of the total number of patients referred for
BPV in our institute during the given period of the study. Of
these infants, 72 had severe valvular PS while four patients pre-
sented with membranous pulmonary atresia with intact inter




Mean age (range) in months 5.63 (0.25–12)
Mean BSA (range) in m2 0.39 (0.22–0.56)
Mean weight (range) in kg 6.39 (3–9.5)
Cyanosis at rest 31.5%
Dysplastic pulmonary valve 13.15%
PFO 59.2%
Associated anomalies
Small VSD 3.94%(n= 3)
Small ASD 19.7%(n= 15)
Small PDA 6.6%(n= 5)
TV disease 5.26%(n= 4)
Isolated PS 64.5%(n= 49)
BSA= body surface area, VSD= ventricular septal defect,
ASD= atrial septal defect, PDA= patent ductus arteriosus,
TV = tricuspid valve, PS = pulmonary stenosis.
Table 2 Baseline echocardiographic data.
Range SD±Mean
Peak PG 60–165 28.2 ± 93.3
RVSP 80–195 115.6 ± 33.8
Pulmonary annulus 4–12 8.14 ± 1.45




PG= pressure gradient, RVSP = right ventricular systolic pres-
sure, PR = pulmonary regurgitation, TR = tricuspid regurgita-
tion, RVH= right ventricular hypertrophy.Age of the patients ranged from 1 week to 12 months with a
mean age of 5.63 ± 2.99 months. There were 48 males (63%)
and 28 females (37%). Weight of the patients ranged from 3
to 9.5 kg with a mean of 6.39 ± 1.57 kg. Calculated body sur-
face area (BSA) ranged from 0.22 to 0.56 m2. Table 1 illus-
trates the clinical and demographic characteristics of the
study group.
Table 2 shows the baseline echocardiographic data mea-
sured before BPV. Four patients with membranous pulmonary
atresia underwent wire perforation of the pulmonary valve;
one of these patients underwent PDA stenting as well. The
remaining patients underwent BPV as previously described in
the literature (Moore and Lock, 2000).
The PV annulus measured from the right lateral angiogram
ranged between 5 and 12 mm with a mean of 8.92 ± 1.44. The
balloon sizes used ranged from 2.5 to 16 mm with a balloon/
annulus ratio ranging from 0.9 to 1.6. Most of the patients
had two consecutive balloon inﬂations (56%). The transvalvu-
lar PG measured during the procedure dropped from a mean of
82.5 ± 23.76 mm Hg before performing the BPV to a mean of
17.35 ± 8.96 after the procedure. There was a signiﬁcant drop
in the RVSP from a mean value of 104.69 ± 24.98 mm Hg to a
mean value of 43.6 ± 13 mm Hg (P value <0.001). The imme-
diate success rate deﬁned as the drop in the RVSP to less than
or equal to 50% of the baseline measurement was achieved in
85% of the cases.
There was a progressive drop in the PG across the PV by
Doppler echocardiogram throughout a follow-up period of
six months from a mean of 93.3 ± 28.2 mm Hg to a mean ofFigure 2 A linear curve showing the progressive drop in the
pressure gradient (PG) across the pulmonary valve throughout a
follow-up period of six months.
igure 3 A linear curve showing the progressive increase in the
ean diameter of the pulmonary valve annulus throughout a
llow-up period of three months.F
m
fo
Table 3 Relation of the degree of PR and the balloon annulus
ratio.
Degree of PR None Mild Moderate Severe
Balloon/annulus
ratio
1.12 ± 0.02 1.29 ± 0.05 1.42 ± 0.09 1.5 ± 0.12
Figure 4 Correlation between the growth of the pulmonary
annulus and the baseline annular size before dilatation.
Figure 6 A linear curve shows a progressive decrease in the
mean diameter of the tricuspid valve annulus throughout the
follow-up of 6 months.
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drop from a mean of 93.3 ± 28.2 mm Hg to a mean of
24.93 ± 13.26 mm Hg 24 h after BPV (P value <0.001), this
drop in the PG was maintained during the follow-up at
3 months with a mean of 19.13 ± 9.91 mm Hg and at
6 months with a mean value of 17.4 ± 10.42 mm Hg.
There was a progressive increase in the mean diameter of
the PV annulus over the same period of follow-up from a mean
value of 8.14 ± 1.45 mm to a mean value of 10.1 ± 1.64 mm.
(Fig. 3). A highly signiﬁcant change has been found in the pul-
monary annulus Z-score with an increase from a mean of
1.567 ± 0.895 to a 6 months post BPV mean of
0.750 ± 0.995. There was a highly signiﬁcant inverse correla-
tion between the growth of the pulmonary annulus and theFigure 5 A linear curve showing the change in the incidence of
both pulmonary regurgitation (PR) and tricuspid regurgitation
(TR) before, immediately after and at 6 month period after
balloon pulmonary valvuloplasty.annular size at the baseline before dilatation (r= 0.74, P
value <0.001) (Fig. 4). The incidence of PR signiﬁcantly
increased immediately after the BPV. The severity of PR
correlated with the increase in balloon/annulus ratio as seen
in Table 3. However, there was a progressive decline in PR
over a 6 months period of follow-up from 64% to 20% of
the patients denoting the transient nature of PR in the majority
of the patients (Fig. 5).
There was a decrease in the mean diameter of the tricuspid
valve annulus from a mean of 17.1 ± 2.65 mm before the pro-
cedure to a mean of 16.24 ± 2.29 mm immediately after the
procedure with less marked decrease during the following
6 months. There was no signiﬁcant change in the tricuspid
annulus Z-score with decrease from a mean of 0.4233 ±
1.214 to a 6 months post BPV mean of 0.1033 ± 1.279 (P va-
lue 0.064). However, there was a signiﬁcant decrease in the
incidence of tricuspid regurgitation (TR) over the same period
of follow-up with a drop in the patients who had TR from
55.6% before the procedure to less than 20% at follow-up.
(Fig. 5 and 6).
No signiﬁcant change has been found in the right ventricu-
lar dimensions immediately after the BPV (19.51 ± 3.49 Vs
19.85 ± 2.28 mm) (P value = 0.51).
Regarding complication during BPV in this age group there
was transient apnea in 46% of the patients, sinus bradycardia
in 27.7% of the patients, self limiting perforations in 3.8% of
the patients and transient loss of femoral pulse in 6.08% of the
patients. The intra-procedure mortality rate was 4.1% (n= 3).
One patient died due to pulmonary annulus rupture while two
patients died due to persistent cardiopulmonary arrest not
responding to resuscitation.
4. Discussion
BPV for congenital valvular PS is effective, safe and currently
considered the therapeutic modality of choice for the treatment
of PS in all age groups regardless of valve morphology (Jarrar
et al., 1999). In the present study successful immediate outcome
of BPV was reported in 85% of the cases. This rate is in close
agreement with that of Moura and coworkers who reported a
success rate of 78% in a similar study group (Moura et al., 2004).
The signiﬁcant immediate reduction of both the RVSP and
the PG across the RVOT in the current study was consistent
200 M.H. Saad et al.with the most recent data published by Karagoz et al. (2009).
There was also a progressive decrease in the PG across the
RVOT throughout the follow-up period from a mean of
24.93 ± 13.26 immediately after BPV to a mean of
17.4 ± 10.42 after 6 months. This was consistent with the data
published in other age groups like that of Sharieff et al. (2003)
who reported a decrease in the PG from 33.5 ± 9.7 mm Hg
immediately after BPV to 18.6 ± 3.4 mm Hg at follow-up.
This ﬁnding might be explained by the gradual regression of
infundibular hypertrophy.
Immediately after BPV we documented a sharp increase in
the incidence of PR that reached 64%. This data was consis-
tent with the data published by Poon and Menahem (2003)
who reported a 61% incidence of PR the day after the proce-
dure. Werynski et al. (2009) reported PR in 39.5% of children
with critical PS immediately after BPV. However, unlike most
of the data published in the literature we report a gradual de-
cline in the incidence of PR to about 20% at 6 months follow-
up (Poon and Menahem, 2003; Rao, 2007).
The current study showed a signiﬁcant increase in the pul-
monary annulus Z-score from a mean of 1.567 ± 0.895 to a
6 months post BPV mean of 0.750 ± 0.995. Tabatabaei et al.
(1996) showed an increase in the pulmonary annulus diameter
Z score from 3 ± 1.0 to 0 ± 0.1. Cazzaniga et al. (2000) also
reported that the RV-PA junction Z -value grew from
1.25 ± 0.9 before valvuloplasty to 0.51 ± 0.7 at follow-
up. This increase in the pulmonary valve annulus toward the
normal values was also consistent with the most recent data
published by Karagoz et al. (2009).
In the current study there was a signiﬁcant decrease in the
number of patients with TR at 6 months compared to the base-
line. This data was consistent with the data in older age groups
like that of Fawzy et al. (2007) who showed that severe TR in
seven patients either regressed or totally disappeared at follow-
up. This was also in accordance with Mechmeche et al. (2000)
who found complete resolution of tricuspid insufﬁciency with-
in 5 years of BPV in patients with severe PS and RV dysfunc-
tion. Similarly, Weber (2002) also demonstrated the regression
of tricuspid valve insufﬁciency and elimination of right to left
shunting at the atrial level in a similar subset of patients.
There was no signiﬁcant change in the tricuspid annulus Z-
score in the current study with decrease from a mean of
0.4233 ± 1.214 to a 6 months post BPV mean of
0.1033 ± 1.279. This result was similar to that obtained by
Cazzaniga et al. (2000) who stated that since the tricuspid
annulus is almost normal in most of the patients studied at
baseline, conﬁguration does not change substantially in the fol-
low-up post BPV.
Regarding the mortality rate; 4.1% of our patients died
compared to 8% of the patients as reported by Tabatabaei
et al. (1996) and 14% of the patients as reported by Karagoz
et al. (2009). This marked difference is due to the older age
group of our patients. It has to be noted that BPV in even old-
er age groups than our patients is reported with almost no
mortality (Rao, 2007).5. Study limitations
Some limitations exist in the present study. These include the
relatively short period of follow-up and the single center source
of data. Multicenter studies with longer follow-up periods areneeded to analyze the important predictors of successful BPV
in infants with severe PS and to study the outcome of this pro-
cedure in patients with critical PS and dysplastic pulmonary
valves.
6. Conclusion
BPV is safe and effective to relieve critical PS in infants during
the ﬁrst year of life. The balloon promotes advantageous
changes in both, pulmonary annulus and PG across the
RVOT. In addition, the Doppler gradient observations during
the follow-up support the expectation that BPV is a ‘‘curative’’
therapy.
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